Los Angeles, CA -- (SBWIRE) -- 04/18/2019 -- Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.

The classification of Inosine Pranobex includes Tablet, Syrup, the sales of Tablet are 8.45 million units, with its market share 69.3%. And the sales market share of Syrup is 30.7% in 2017.

Inosine Pranobex is widely used to treat Immunomodulation, Antiviral and Other. The most proportion of Inosine Pranobex is to treat Antiviral, and the proportion is about 48.6% in 2017.

Europe region is the largest supplier of Inosine Pranobex, with a production market share nearly 57% in 2017. North America is the second largest supplier of Inosine Pranobex, enjoying revenue market share nearly 8.7% in 2017.

The global Inosine Pranobex market was 180 million US$ in 2018 and is expected to 220 million US$ by the end of 2025, growing at a CAGR of 2.2% between 2019 and 2025.

This report studies the Inosine Pranobex market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Get PDF of this report template: https://www.qyresearch.com/sample-form/form/1092539/global-inosine-pranobex-market

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Inosine Pranobex in these regions, from 2014 to 2025, covering

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

South America (Brazil etc.)

Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

Newport Pharmaceuticals

Gedeon Richter

Mochida

Sanofi

Andrómaco

Yung Shin

Sigma -Tau

Polfarmex

Sanfer

Meprofarm

Novell Pharmaceutical

Aflofarm

By the product type, the market is primarily split into

Tablet

Syrup

By the end users/application, this report covers the following segments

Immunomodulation

Antiviral

Other

Get Full Report Now at USD 3,350: https://www.qyresearch.com/settlement/pre/7e1f6d4e3a5754dfe4171bfa30b9bfc7,0,1,Global%20Inosine%20Pranobex%20Market%20Report,%20History%20and%20Forecast%202014-2025,%20Breakdown%20Data%20by%20Manufacturers,%20Key%20Regions,%20Types%20and%20Application

Benefits of Purchasing QY Research Report
- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
- Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report

About QYResearch 
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.